Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1979 1
1980 1
1981 3
1982 3
1983 5
1984 5
1985 2
1986 8
1987 11
1988 16
1989 10
1990 7
1991 10
1992 11
1993 11
1994 11
1995 19
1996 17
1997 20
1998 25
1999 21
2000 37
2001 45
2002 57
2003 48
2004 77
2005 95
2006 93
2007 120
2008 138
2009 176
2010 201
2011 245
2012 319
2013 348
2014 381
2015 475
2016 512
2017 557
2018 672
2019 770
2020 891
2021 1048
2022 1231
2023 1242
2024 1041
2025 6

Text availability

Article attribute

Article type

Publication date

Search Results

9,901 results

Results by year

Filters applied: . Clear all
Page 1
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase.
Guo Y, Liu Y, Hu N, Yu D, Zhou C, Shi G, Zhang B, Wei M, Liu J, Luo L, Tang Z, Song H, Guo Y, Liu X, Su D, Zhang S, Song X, Zhou X, Hong Y, Chen S, Cheng Z, Young S, Wei Q, Wang H, Wang Q, Lv L, Wang F, Xu H, Sun H, Xing H, Li N, Zhang W, Wang Z, Liu G, Sun Z, Zhou D, Li W, Liu L, Wang L, Wang Z. Guo Y, et al. Among authors: cheng z. J Med Chem. 2019 Sep 12;62(17):7923-7940. doi: 10.1021/acs.jmedchem.9b00687. Epub 2019 Aug 19. J Med Chem. 2019. PMID: 31381333
Blood-based biomarkers for Alzheimer's disease: a multicenter-based cross-sectional and longitudinal study in China.
Gao F, Dai L, Wang Q, Liu C, Deng K, Cheng Z, Lv X, Wu Y, Zhang Z, Tao Q, Yuan J, Li S, Wang Y, Su Y, Cheng X, Ni J, Wu Z, Zhang S, Shi J, Shen Y; China Aging and Neurodegenerative Initiative (CANDI) Consortium. Gao F, et al. Among authors: cheng z. Sci Bull (Beijing). 2023 Aug 30;68(16):1800-1808. doi: 10.1016/j.scib.2023.07.009. Epub 2023 Jul 10. Sci Bull (Beijing). 2023. PMID: 37500404 Free article.
Three-dimensional valley-contrasting sound.
Xue H, Ge Y, Cheng Z, Guan YJ, Zhu J, Zou HY, Yuan SQ, Yang SA, Sun HX, Chong Y, Zhang B. Xue H, et al. Among authors: cheng z. Sci Adv. 2024 Sep 13;10(37):eadp0377. doi: 10.1126/sciadv.adp0377. Epub 2024 Sep 11. Sci Adv. 2024. PMID: 39259802 Free PMC article.
Dermatopathic Lymphadenitis.
Hu N, Tan YL, Cheng Z, Wang YH. Hu N, et al. Among authors: cheng z. Chin Med J (Engl). 2015 Nov 20;128(22):3121-2. doi: 10.4103/0366-6999.169172. Chin Med J (Engl). 2015. PMID: 26609001 Free PMC article. No abstract available.
Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial.
Wang C, Zhai Z, Yang Y, Wu Q, Cheng Z, Liang L, Dai H, Huang K, Lu W, Zhang Z, Cheng X, Shen YH; China Venous Thromboembolism (VTE) Study Group. Wang C, et al. Among authors: cheng z. Chest. 2010 Feb;137(2):254-62. doi: 10.1378/chest.09-0765. Epub 2009 Sep 9. Chest. 2010. PMID: 19741062 Free PMC article. Clinical Trial.
9,901 results